{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:58:39Z","timestamp":1792425519392,"version":"4.5.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Antibiot."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The incidence of ESBL infections is exponentially increasing with variable prevalence among geographical areas and treatment settings. Identifying local prevalence rate and patient-related factors will help in earlier recognition and initiation of appropriate antibiotics treatment of patients with ESBL infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective analysis of all positive cultures for ESBL producing Enterobacteriaceae collected in Al-Khor hospital from January 2010 to December 2012. ESBL bacterial isolates reported as cephalosporin-resistant or ESBL using the automated VITEK Gram-Negative Susceptibility System with cards GNS 206 and 121 were screened for ESBL detection using the disk diffusion method in keeping with the Clinical and Laboratory Standards Institute. Both descriptive and analytic statistics were applied when appropriate, and univariate analysis was used to identify significant factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Most of the ESBL-producing bacterial isolates were <jats:italic>E. coli<\/jats:italic>, which were also resistant to other classes of antimicrobials. Meropenem, amikacin and nitrofurantoin retained good coverage to most isolates. Klebsiella pneumonia infection was most likely associated with diabetes mellitus (<jats:italic>p<\/jats:italic> = 0.004), hospital-acquired infection (<jats:italic>p<\/jats:italic> = 0.046) and with more severe infection (<jats:italic>p<\/jats:italic> = 0.006). ESBL associated hospital-acquired infections were more likely to occur in older patients, those with comorbidities and with invasive device use. ESBL-associated urinary tract infections were most commonly community-acquired while ESBL associated respiratory tract infections were acquired from hospitals (<jats:italic>p<\/jats:italic> = &amp;lt; 0.001). Factors associated with mortality include treatment in the ICU (OR 104.8 [9.82\u20131116.96] <jats:italic>p<\/jats:italic> &amp;lt; 0.001), sepsis\/septic shock (OR 20.80 (5.68\u201376.12) <jats:italic>p<\/jats:italic> &amp;lt; 0.001), hospital-acquired infections (OR 8.80 [1.88\u201341.16] <jats:italic>p<\/jats:italic> = 0.006) and bacteremia (OR 8.80 [1.63\u201347.5] <jats:italic>p<\/jats:italic> = 0.013).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Multiple risk factors were associated with ESBL infections both in the community and hospital setting. Prediction tools are needed to improve the protocol of appropriate empiric antibiotic selection while preserving antimicrobial stewardship recommendations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/frabi.2022.980686","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T04:38:40Z","timestamp":1662525520000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Epidemiology of extended-spectrum beta-lactamase producing Enterobacteriaceae in Qatar: A 3-year hospital-based study"],"prefix":"10.3389","volume":"1","author":[{"given":"Musaed","family":"Alsamawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar I.","family":"Joudeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaseer","family":"Eldeeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Al-Dahshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahmi","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wissam","family":"Ghadban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna","family":"Almaslamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulatif","family":"Alkhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.idc.2020.06.003","article-title":"The continuing plague of extended-spectrum \u03b2-lactamase producing enterbacterales infections: an update","volume":"34","author":"Adler","year":"2020","journal-title":"Infect. Dis. Clin"},{"key":"B2","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement; M100-S20","year":"2010"},{"key":"B3","unstructured":"Cdc.gov2022"},{"key":"B4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/cid\/cis942","article-title":"Community-associated extended-spectrum \u03b2-lactamase\u2013producing Escherichia coli infection in the United States","volume":"56","author":"Doi","year":"2013","journal-title":"Clin. Infect. Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jinf.2015.08.012","article-title":"Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: a matched cohort study","volume":"71","author":"Esteve-Palau","year":"2015","journal-title":"J. Infect"},{"key":"B6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care\u2013associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann. Internal Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am. J. Infect. Control"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1086\/507962","article-title":"Impact of extended-spectrum \u03b2-lactamase\u2013producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study","volume":"27","author":"Lee","year":"2006","journal-title":"Infect. Control Hospital Epidemiol"},{"key":"B9","volume-title":"Extended-Spectrum Beta-Lactamases","author":"Munoz-Price","year":"2019"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1128\/AAC.05650-11","article-title":"Clinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United States","volume":"56","author":"Park","year":"2012","journal-title":"Antimicrob. Agents Chemother"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1128\/AAC.00627-10","article-title":"Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis","volume":"54","author":"Paul","year":"2010","journal-title":"Antimicrob. Agents Chemother"},{"key":"B12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2165\/11533040-000000000-00000","article-title":"Infections with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae","volume":"70","author":"Pitout","year":"2010","journal-title":"Drugs"},{"key":"B13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect. Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/jac\/dki166","article-title":"Emergence of Enterobacteriaceae producing extended-spectrum \u03b2-lactamases (ESBLs) in the community","volume":"56","author":"Pitout","year":"2005","journal-title":"J. Antimicrob. Chemotherapy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e00079","DOI":"10.1128\/CMR.00079-17","article-title":"Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae","volume":"31","author":"Rodr\u00edguez-Ba\u00f1o","year":"2018","journal-title":"Clin. Microbiol. Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/jac\/dkm318","article-title":"Mortality and delay in effective therapy associated with extended-spectrum \u03b2-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis","volume":"60","author":"Schwaber","year":"2007","journal-title":"J. Antimicrob. Chemother"},{"key":"B17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2217\/fmb.15.16","article-title":"The complex epidemiology of extended-spectrum beta-lactamase-producing enterobacteriaceae","volume":"10","author":"Tal Jasper","year":"2015","journal-title":"Future Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0195258","DOI":"10.1371\/journal.pone.0195258","article-title":"Invasive infection caused by Klebsiella pneumoniae is a disease affecting patients with high comorbidity and associated with high long-term mortality","volume":"13","author":"Vading","year":"2018","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Antibiotics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frabi.2022.980686\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T04:38:47Z","timestamp":1662525527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frabi.2022.980686\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":19,"alternative-id":["10.3389\/frabi.2022.980686"],"URL":"https:\/\/doi.org\/10.3389\/frabi.2022.980686","relation":{},"ISSN":["2813-2467"],"issn-type":[{"value":"2813-2467","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"article-number":"980686"}}